N. W. Keiser and J. F. Engelhardt, New animal models of cystic fibrosis: what are they teaching us?, Curr Opin Pulm Med, vol.17, pp.478-483, 2011.

C. Guilbault, Z. Saeed, G. P. Downey, and D. Radzioch, Cystic fibrosis mouse models, Am J Respir Cell Mol Biol, vol.36, pp.1-7, 2007.

B. R. Grubb and R. C. Boucher, Pathophysiology of gene-targeted mouse models for cystic fibrosis, Physiol Rev, vol.79, pp.193-214, 1999.

B. H. Rosen, M. Chanson, and L. R. Gawenis, Animal and model systems for studying cystic fibrosis, J Cyst Fibros, vol.17, pp.28-34, 2018.

X. Sun, H. Sui, and J. T. Fisher, Disease phenotype of a ferret CFTRknockout model of cystic fibrosis, J Clin Invest, vol.120, pp.3149-3160, 2010.

C. S. Rogers, D. A. Stoltz, and D. K. Meyerholz, Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs, Science, vol.321, pp.1837-1841, 2008.

J. H. Widdicombe, L. L. Chen, H. Sporer, H. K. Choi, I. S. Pecson et al., Distribution of tracheal and laryngeal mucous glands in some rodents and the rabbit, J Anat, vol.198, pp.207-221, 2001.

K. L. Tuggle, S. E. Birket, and X. Cui, Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats, PLoS ONE, vol.9, p.91253, 2014.

M. S. Stalvey, V. Havasi, and K. L. Tuggle, Reduced bone length, growth plate thickness, bone content, and IGF-I as a model for poor growth in the CFTR-deficient rat, PLoS ONE, vol.12, p.188497, 2017.

S. E. Birket, J. M. Davis, and C. M. Fernandez, Development of an airway mucus defect in the cystic fibrosis rat, JCI Insight, vol.3, p.97199, 2018.

J. J. Smolich, B. F. Stratford, J. E. Maloney, and B. C. Ritchie, New features in the development of the submucosal gland of the respiratory tract, J Anat, vol.127, pp.223-238, 1978.

J. C. Cohen and J. E. Larson, Pathophysiologic consequences following inhibition of a CFTR-dependent developmental cascade in the lung, BMC Dev Biol, vol.5, issue.2, 2005.

A. Dreano-et,

T. Li, S. Koshy, and H. G. Folkesson, RNA interference for CFTR attenuates lung fluid absorption at birth in rats, Respir Res, vol.9, p.55, 2008.

S. Ménoret, A. De-cian, and L. Tesson, Homology-directed repair in rodent zygotes using Cas9 and TALEN engineered proteins, Sci Rep, vol.5, p.14410, 2015.

V. Chenouard, L. Brusselle, and J. Heslan, A rapid and cost-effective method for genotyping genome-edited animals: a heteroduplex mobility assay using microfluidic capillary electrophoresis, J Genet Genomics, vol.43, pp.341-348, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02150677

E. L. Saussereau, D. Roussel, S. Diallo, L. Debarbieux, and A. Edelman, Sermet-Gaudelus I. Characterization of nasal potential difference in cftr knockout and F508del-CFTR mice, PLoS ONE, vol.8, p.57317, 2013.

C. Cottart, E. Bonvin, and C. Rey, Impact of nutrition on phenotype in CFTR-deficient mice, Pediatr Res, vol.62, pp.528-532, 2007.

Z. E. Plyler, S. E. Birket, and B. D. Schultz, Non-obstructive vas deferens and epididymis loss in cystic fibrosis rats, Mech Dev, vol.155, pp.15-26, 2019.

T. Azevedo, G. Feijó, and A. Bezerra, Presence of developmental defects of enamel in cystic fibrosis patients, J Dent Child (Chic), vol.73, pp.159-163, 2006.

B. Lubamba, J. Lebacq, and G. Reychler, Inhaled phosphodiesterase type 5 inhibitors restore chloride transport in cystic fibrosis mice, Eur Respir J, vol.37, pp.72-78, 2011.

J. H. Van-doorninck, P. J. French, and E. Verbeek, A mouse model for the cystic fibrosis delta F508 mutation, EMBO J, vol.14, pp.4403-4411, 1995.

M. Wilke, R. M. Buijs-offerman, and J. Aarbiou, Mouse models of cystic fibrosis: phenotypic analysis and research applications, J Cyst Fibros, vol.10, pp.152-171, 2011.

L. S. Ostedgaard, C. S. Rogers, and Q. Dong, Processing and function of CFTR-DeltaF508 are species-dependent, Proc Natl Acad Sci USA, vol.104, pp.15370-15375, 2007.

L. S. Ostedgaard, D. K. Meyerholz, and J. H. Chen, The ?F508 mutation causes CFTR misprocessing and cystic fibrosis-like disease in pigs, Sci Transl Med, vol.3, pp.74-98, 2011.

K. E. Tipirneni, D. Cho, and D. F. Skinner, Characterization of primary rat nasal epithelial cultures in CFTR knockout rats as a model for CF sinus disease, Laryngoscope, vol.127, pp.384-391, 2017.

P. A. Flume, T. G. Liou, and D. S. Borowitz, Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation, Chest, vol.142, pp.718-724, 2012.

J. P. Clancy, S. M. Rowe, and F. J. Accurso, Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation, Thorax, vol.67, pp.12-18, 2012.

C. E. Wainwright, J. S. Elborn, and B. W. Ramsey, Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR, N Engl J Med, vol.373, pp.220-231, 2015.

G. Cui and N. Mccarty, Murine and human CFTR exhibit different sensitivities to CFTR potentiators, Am J Physiol Lung Cell Mol Physiol, vol.309, pp.687-699, 2015.

S. J. Bose, M. Bijvelds, and Y. Wang, Differential thermostability and response to cystic fibrosis transmembrane conductance regulator (CFTR) potentiators of human and mouse F508del-CFTR, Am J Physiol Lung Cell Mol Physiol, vol.317, pp.71-86, 2019.

E. Dreano, M. Bacchetta, and J. Simonin, Characterization of two rat models of cystic fibrosis-KO and F508del CFTR-Generated by Crispr-Cas9, Animal Model Exp Med, vol.2, pp.297-311, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02458316